Study to test the safety and efficacy of using both Benzoyl peroxide/ Clindamycin gel and Tazarotene cream in combination to treat Acne. - Trial 2015-004900-44
Access comprehensive clinical trial information for 2015-004900-44 through Pure Global AI's free database. This phase not specified trial is sponsored by GlaxoSmithKline Research & Development and is currently status unknown. The study focuses on Acne Vulgaris.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
GlaxoSmithKline Research & Development
GlaxoSmithKline
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
The absolute change in lesion counts (total, inflammatory, noninflammatory) from baseline to week 12. The proportion of subjects who have a minimum 2-grade improvement in ISGA score from baseline to week 12.
ICD-10 Classifications
Data Source
EU Clinical Trials Register
2015-004900-44
Non-Device Trial